Be a Smart Investor
Monday, January 23, 2017
Gainers & Losers Of The Day: ACST, MRNS, BIOA, APTO, PULM...
Marinus Pharmaceuticals Inc. has reported positive preliminary data from its phase II trial of Ganaxolone in children with CDKL5 genetic disorder.
from RTT - Biotech http://ift.tt/2jjLioC
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment